Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness (Front. Cell Dev. Biol, (2020), 8, (287), 10.3389/fcell.2020.00287)

doi:10.3389/fcell.2020.594589

科研成果详情

名称	Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness (Front. Cell Dev. Biol, (2020), 8, (287), 10.3389/fcell.2020.00287)
作者	Quan, Mei-Yu1,2; Guo, Qiang1,2; Liu, Jiayu 3; Yang, Ruo 1,2; Bai, Jing 1,2; Wang, Wei 1,2; Cai, Yaxin 3; Han, Rui 1,2; Lv, Yu-Qing4; Ding, Li 5,6; Billadeau, Daniel D.5,6; Lou, Zhenkun 5,6; Bellusci, Saverio 3,7,8; Li, Xiaokun1,2; Zhang, Jin-San1,2,3
发表期刊	Frontiers in Cell and Developmental Biology;
语种	英语
原始文献类型	Erratum
关键词	FGFR pancreatic cancer SOX2 sphere-formation assay stemness
摘要	In the original article, there was a mistake in Figures 2C, 6B, and S3C as published. The control tubulin immunoblot shown in Figure S3C and microscopy of sphere-formation assay in Figures 2C and 6B were redundantly used. The corrected Figures 2C, 6B, and S3C appear below. The authors apologize for these errors and state that these corrections do not change the scientific conclusions of the article in any way. The original article has been updated.
出版者	FRONTIERS MEDIA SA
ISSN	2296-634X
卷号	8
DOI	10.3389/fcell.2020.594589
页数	4
WOS类目	Cell Biology ; Developmental Biology
WOS研究方向	Cell Biology ; Developmental Biology
WOS记录号	WOS:000577710700001
收录类别	SCOPUS ; SCIE
发布日期	2020-10-02
URL	查看原文
PubMed ID	33117821
通讯作者地址	[Li, Xiaokun;Zhang, Jin-San]Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China. ; [Li, Xiaokun;Zhang, Jin-San]Wenzhou Med Univ, Int Collaborat Ctr Growth Factor Res, Wenzhou, Peoples R China. ; [Zhang, Jin-San]Wenzhou Univ, Inst Life Sci, Wenzhou, Peoples R China.
Scopus学科分类	Developmental Biology;Cell Biology
SCOPUSEID	2-s2.0-85092783373
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/185277
专题	药学院（分析测试中心）附属第一医院卓越中心_国际生长因子研究院
通讯作者	Li, Xiaokun; Zhang, Jin-San
作者单位	1.Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China; 2.Wenzhou Med Univ, Int Collaborat Ctr Growth Factor Res, Wenzhou, Peoples R China; 3.Wenzhou Univ, Inst Life Sci, Wenzhou, Peoples R China; 4.Wenzhou Med Univ, Ctr Precis Med, Affiliated Hosp 1, Wenzhou, Peoples R China; 5.Mayo Clin, Div Oncol Res, Rochester, MN USA; 6.Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN USA; 7.Justus Liebig Univ Giessen, Cardiopulm Inst, Giessen, Germany; 8.Justus Liebig Univ Giessen, German Lung Ctr, Giessen, Germany
第一作者单位	药学院（分析测试中心）; 温州医科大学
通讯作者单位	药学院（分析测试中心）; 温州医科大学
推荐引用方式 GB/T 7714	Quan, Mei-Yu,Guo, Qiang,Liu, Jiayu,et al. Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness (Front. Cell Dev. Biol, (2020), 8, (287), 10.3389/fcell.2020.00287). 2020.